Oruka Therapeutics (ORKA) Return on Assets (2011 - 2025)

Oruka Therapeutics' Return on Assets history runs 15 years deep, the most recent figure standing at 0.0% for Q1 2025.

• On a quarterly basis, Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2025; TTM through Mar 2025 was 0.0%, a 0.0% change from a year earlier, with the FY2023 full-year figure at 0.02%, changed 0.0% from the prior year.
• Return on Assets improved to 0.0% in Q1 2025 per ORKA's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q1 2025 and bottomed at 0.01% in Q2 2024.
• The 5-year median for Return on Assets is 0.0% (2022), against an average of 0.0%.
• Across the five-year window, Return on Assets changed 0 bps in 2021 and declined 1 bps in 2024, its largest moves.
• Year by year, Return on Assets stood at 0.0% in 2021, then rose by 29 bps to 0.0% in 2022, then surged by 37 bps to 0.0% in 2023, then jumped by 59 bps to 0.0% in 2024, then increased by 24 bps to 0.0% in 2025.
• Per Business Quant, the three latest ORKA Return on Assets figures stand at 0.0% (Q1 2025), 0.0% (Q4 2024), and 0.0% (Q3 2024).